Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

被引：0
|
作者：
Sato, Takayuki [1 ]
Ochi, Shinichi [1 ]
Nagayama, Takashi [1 ]
Nabe, Shogo [1 ]
Sakai, Kazuya [1 ]
Muranushi, Hiroyuki [1 ]
Okamoto, Yusuke [1 ]
Sugiura, Hiroyuki [1 ]
Okada, Kazuya [1 ]
Sato, Aki [1 ]
Maeda, Takeshi [1 ]
Onishi, Tatsuhito [1 ]
Ueda, Yasunori [1 ]
机构：
[1] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Developing a Modified Hematopoietic Stem Cell Transplantation-Comorbidity Index for Adolescents and Young Adults
    Friend, Brian D.
    Tang, Kevin
    Markovic, Daniela
    Schiller, Gary J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S293 - S294
  • [2] Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation
    Mo, Xiaodong
    Zhang, Xiaohui
    Xu, Lanping
    Wang, Yu
    Yan, Chenhua
    Chen, Huan
    Chen, Yuhong
    Han, Wei
    Wang, Fengrong
    Wang, Jingzhi
    Liu, Sining
    Liu, Kaiyan
    Huang, Xiaojun
    BLOOD, 2019, 134
  • [3] Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation
    Mo, Xiao-Dong
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Liu, Kai-Yan
    Huang, Xiao-Jun
    ENGINEERING, 2021, 7 (02) : 162 - 169
  • [4] Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians
    Broglie, Larisa
    Friend, Brian D.
    Chhabra, Saurabh
    Bupp, Caitrin
    Schiller, Gary J.
    Logan, Brent
    Pasquini, Marcelo C.
    Savani, Bipin
    Stadtmauer, Edward A.
    Thakar, Monica S.
    Sorror, Mohamed
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2507 - 2510
  • [5] Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
    Sorror, Mohamed
    Storer, Barry
    Sandmaier, Brenda M.
    Maloney, David G.
    Chauncey, Thomas R.
    Langston, Amelia
    Maziarz, Richard T.
    Pulsipher, Michael
    McSweeney, Peter A.
    Storb, Rainer
    CANCER, 2008, 112 (09) : 1992 - 2001
  • [6] A modified comorbidity index for hematopoietic cell transplantation
    T E DeFor
    N S Majhail
    D J Weisdorf
    C G Brunstein
    S McAvoy
    M Arora
    C T Le
    Bone Marrow Transplantation, 2010, 45 : 933 - 938
  • [7] A modified comorbidity index for hematopoietic cell transplantation
    DeFor, T. E.
    Majhail, N. S.
    Weisdorf, D. J.
    Brunstein, C. G.
    McAvoy, S.
    Arora, M.
    Le, C. T.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 933 - 938
  • [8] A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation
    Qayed, Muna
    Ahn, Kwang Woo
    Kitko, Carrie L.
    Johnson, Mariam H.
    Shah, Nirali N.
    Dvorak, Christopher
    Mellgren, Karin
    Friend, Brian D.
    Verneris, Michael R.
    Leung, Wing
    Toporski, Jacek
    Levine, John
    Chewning, Joseph
    Wayne, Alan
    Kapoor, Urvi
    Triplett, Brandon
    Schultz, Kirk R.
    Yanik, Gregory A.
    Eapen, Mary
    BLOOD, 2021, 137 (07) : 983 - 993
  • [9] Hematopoietic cell transplantation-comorbidity index (HCT-CL): A valid tool to predict morbidity risk in patients undergoing autologous HCT (AHCT) for lymphoma
    Kassar, M.
    Shell, K.
    Gregory, S. A.
    Venugopal, P.
    Shamino, J.
    Fung, H. C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 22 - 23
  • [10] Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation
    Bejanyan, Nelli
    Brunstein, Claudio G.
    Cao, Qing
    Lazaryan, Aleksandr
    Ustun, Celalettin
    Warlick, Erica D.
    Arora, Mukta
    Wagner, John E.
    Weisdorf, Daniel J.
    BLOOD ADVANCES, 2019, 3 (03) : 230 - 236
12345